Three Rocky Mount Vape Shops Accused of Selling Illegal Cannabis-Related Products
Three Rocky Mount vape shops are accused of selling illegal cannabis vape products, raising concerns about unregulated cannabis vape safety. These products often lack proper testing and regulation, posing risks to patients. Enforcement actions emphasize…
Prop. 64 at 10: Why the Illicit Cannabis Market Still Dominates in California
California cannabis legalization challenges persist a decade after Prop. 64, with the illicit market still dominating. This affects patient safety due to unregulated product quality and dosing inconsistencies. Clinicians must understand these challenges…
Cannabis Bioscience International Holdings — Q1 10-Q: Revenues $11.2K, EPS $(0.000009)
The cannabis bioscience international holdings Q1 report reveals minimal revenues and earnings, highlighting financial challenges for small cannabis companies. These challenges may affect product quality and availability in the cannabis market.…
Hot Picks: Cannabis consolidation and global demand fuel sector outlook
The cannabis sector outlook 2026 highlights key trends in market consolidation and global demand shaping the industry. These developments influence medical cannabis product quality and research funding. Understanding this outlook is essential for…
Cannabis Purity Concerns Grow As Consumers Shift From Alcohol
Cannabis product purity is a growing concern as more consumers shift from alcohol to cannabis. Contamination and inconsistent quality control pose critical safety challenges. Clinicians must understand these issues to guide patients effectively.
Colorado Regulators Target Hemp THC Inversion for Product Safety
Hemp regulation product safety is critical as Colorado cannabis regulators promise a crackdown on THC inversion. This enforcement aims to improve product quality and protect patient safety. Understanding these regulatory changes helps clinicians advise…
‘Slow as molasses:’ Cannabis cultivators decry licensing delays in Rhode Island
Rhode Island cannabis licensing delays are causing frustration among cultivators and applicants. These regulatory bottlenecks impact patient access to quality-controlled cannabis products. Patients may turn to unregulated sources when licensing stalls,…
Alex Miller on Cannabis Facilities: Canada’s Large-Scale Advantage
Canada cannabis production facilities play a crucial role in ensuring product consistency and quality control. These large-scale operations support reliable supply chains for medical cannabis. Understanding Canada’s regulatory framework helps clinicians…
$80M Cannabis Bust Leads to $50K Fine for Leamington Company
The 80M cannabis seizure regulatory impact highlights enforcement actions affecting medical cannabis supply chains. A $50K fine was issued against a Leamington company for compliance violations. These regulatory measures emphasize the importance of…
Maine Debates Optimal Medical Cannabis Testing and Tracking
Maine is evaluating medical cannabis testing methods to improve product safety and quality control. These methods ensure accurate potency and contaminant screening. Effective tracking supports regulatory compliance and patient safety.
